Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
January 06, 2025 08:30 ET
|
Dyadic International, Inc.
Dyadic Provides Business Update
Dyadic to Attend the
43rd Annual J.P. Morgan Healthcare Conference
Dyadic Announces Third Quarter 2024 Financial Results and Strategic Progress Across Key Markets
November 12, 2024 16:05 ET
|
Dyadic International, Inc.
Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms Alternative Proteins Demonstrated substantial revenue...
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
November 04, 2024 16:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient...
Dyadic Expands Global Presence with Participation in Key Industry Events
October 09, 2024 08:00 ET
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of...
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
September 23, 2024 09:50 ET
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient,...